moatshark My

All holdings

Zimmer Biomet Holdings

ZBH

Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them

Managers holding
3
In their latest 13F (Q3 2026)
See who
Value held
$3.2bn
Combined value at quarter end
Last quarter
1 bought
2 sold or trimmed
Fund portfolios
1
Funds holding it
See which
Price at Q2 ’26 end
$86.09
-4.8% in the quarter

Prices here are quarter-end prices implied by the 13F filings. Today’s price on Yahoo Finance

Share price change by quarter

-0.5%Q3 ’24
-2.1%Q4 ’24
+7.1%Q1 ’25
-19.4%Q2 ’25
+8.0%Q3 ’25
-8.7%Q4 ’25
+0.6%Q1 ’26
-4.8%Q2 ’26
Q3 ’24: -0.5%; Q4 ’24: -2.1%; Q1 ’25: +7.1%; Q2 ’25: -19.4%; Q3 ’25: +8.0%; Q4 ’25: -8.7%; Q1 ’26: +0.6%; Q2 ’26: -4.8%

Change in the quarter-end price implied by managers’ 13F filings, adjusted for stock splits. Excludes dividends.

Managers holding it, by quarter

4Q4 ’23
4Q1 ’24
4Q2 ’24
4Q3 ’24
4Q4 ’24
4Q1 ’25
5Q2 ’25
5Q3 ’25
4Q4 ’25
3Q1 ’26
3Q2 ’26
0Q3 ’26
Q4 ’23: 4; Q1 ’24: 4; Q2 ’24: 4; Q3 ’24: 4; Q4 ’24: 4; Q1 ’25: 4; Q2 ’25: 5; Q3 ’25: 5; Q4 ’25: 4; Q1 ’26: 3; Q2 ’26: 3; Q3 ’26: 0

Counts the managers on this site whose 13F for that quarter includes Zimmer Biomet Holdings.

Who holds it

Each manager’s latest 13F, sorted by how much of their portfolio it is. Changes are against their previous quarter.

Managers holding Zimmer Biomet Holdings
Harris Associates (Oakmark)1.4%$1.1bn$1.1bnTrimmed -1.7%5 qtrs
Dodge & Cox1.1%$2.1bn$2.1bnAdded +2.5%18 qtrs
Mairs & Power0.0%$570k$570kTrimmed -18%53 qtrs

Download the holders: CSV · JSON · Markdown

Directors buying and selling

Open-market trades by directors, officers and 10% holders over the last 12 months. How this works
From their Form 4 filings with the SEC. Grants, option exercises and shares sold to pay tax are left out.
Insider purchases and sales of Zimmer Biomet Holdings
Bought or soldFiling
11 Sep 2026Thornal Kevin RGrp Pres-Global Business▼ Sold5,691$92.95$529kForm 4
4 Sep 2026Phipps Chad FSee remarks below.▼ Sold3,000$98.35$295kForm 4

About the company

Sector
Health care · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Incorporated in
Delaware
Financial year ends
31 December
Shares outstanding
191m at 30 Jul 2026
SEC filings
Annual reports and other filings on EDGAR

Revenue and profit

2013
2015
$7.8bn2017
$7.0bn2019
$6.8bn2021
$7.4bn2023
$8.2bn2025
2013: not held; 2014: not held; 2015: not held; 2016: $7.7bn; 2017: $7.8bn; 2018: $7.9bn; 2019: $7.0bn; 2020: $6.1bn; 2021: $6.8bn; 2022: $6.9bn; 2023: $7.4bn; 2024: $7.7bn; 2025: $8.2bn
Zimmer Biomet Holdings revenue and net income by year
YearRevenueNet income
2025$8.2bn$705m
2024$7.7bn$904m
2023$7.4bn$1.0bn
2022$6.9bn$231m
2021$6.8bn$402m
2020$6.1bn−$139m
2019$7.0bn$1.1bn
2018$7.9bn−$379m
2017$7.8bn$1.8bn
2016$7.7bn$306m
2015–$147m
2014–$720m
2013–$780m

From the company’s XBRL financial statements filed with the SEC, for each financial year. Gaps mean the company didn’t report that figure in a standard form.

In fund portfolios

US-registered funds run by these managers that hold Zimmer Biomet Holdings, from their latest N-PORT filings.

Funds holding Zimmer Biomet Holdings
Dodge & Cox Global Stock FundDodge & Cox1.0%$128m30 Jun 2026